(Q37603718)

English

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report

scientific article published on February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

relapsing-remitting multiple sclerosis

0 references

multiple sclerosis

0 references

10

object named as

Olaf Stüve

1 reference

Europe PubMed Central

21 August 2017

PMC publication ID

8

object named as

Harry Openshaw

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Richard A Nash

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

George J Hutton

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Michael K Racke

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Uday Popat

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Steven M Devine

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Linda M Griffith

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Paolo A Muraro

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Peter H Sayre

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Douglas L Arnold

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Meagan E Spychala

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Kaitlyn C McConville

13

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Kristina M Harris

14

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Deborah Phippard

15

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

George E Georges

16

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Annette Wundes

17

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

George H Kraft

18

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

James D Bowen

19

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

0 references

publication date

1 February 2015

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

72

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

159-169

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

T cell repertoire following autologous stem cell transplantation for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

The challenge of follow-on biologics for treatment of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

The relation between inflammation and neurodegeneration in multiple sclerosis brains.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Cause of death in patients attending multiple sclerosis clinics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

23 August 2017

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

28 September 2017

Cognitive fatigue in individuals with multiple sclerosis undergoing immunoablative therapy and hematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

Autologous hematopoietic stem cell transplantation as a treatment option for aggressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

1 September 2018

Long-term results of stem cell transplantation for MS: A single-center experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

3 December 2018

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5261862

3 December 2018

Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system

1 reference

https://pubmed.ncbi.nlm.nih.gov/25546364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suicidal ideation in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25546364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

1 reference

https://pubmed.ncbi.nlm.nih.gov/25546364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/25546364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25546364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMANEUROL.2014.3780

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37603718&oldid=1878183354"